Interesting comments. IMO this only acts to accelerate our momentum. The competition must act now, sooner than later or risk someone else doing so. I would not be surprised to see some corporate action before the end of the year. Hopefully a partnership as our MC is way too low to entertain a takeover.
So yes, commercialisation is a while off but that does not mean that an increase in our valuation is as well.
Make no mistake. This presentation was a watershed moment for the company that changes everything.
That VIV result was astounding - we literally put a VIV and improved the original result (never possible before). Valve break down will accelerate over the next 5 years as they are put into younger patients and the opportunity is enormous. It will also be key to breakthrough status related to the perfect laminar flow.
Exciting times ahead.
Not advice and do your own research.
BEYOND DOUBT NOW THAT THIS IS THE REAL DEAL - sub 300 mil usd MC with the worlds best TAVR.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)